Dunleavy K - Search Results

1

Toxicity and efficacy of CAR T-cell therapy in primary and secondary CNS lymphoma: a meta-analysis of 128 patients.

Cook MR, Dorris CS, Makambi KH, Luo Y, Munshi PN, Donato M, Rowley S, Saad A, Goy A, Dunleavy K, Ali A. Cook MR, et al. Among authors: dunleavy k. Blood Adv. 2023 Jan 10;7(1):32-39. doi: 10.1182/bloodadvances.2022008525. Blood Adv. 2023. PMID: 36260735 Free PMC article.

2

Scouting out the neighborhood in AIDS-related lymphoma.

Dunleavy K, Bollard CM. Dunleavy K, et al. Blood. 2013 Jul 18;122(3):306-7. doi: 10.1182/blood-2013-06-502591. Blood. 2013. PMID: 23869074 Free PMC article.

3

Optimizing outcomes in primary mediastinal B-cell lymphoma: is R-CHOP enough?

Cook MR, Dunleavy K. Cook MR, et al. Among authors: dunleavy k. Blood Adv. 2021 Oct 12;5(19):3873-3875. doi: 10.1182/bloodadvances.2021005190. Blood Adv. 2021. PMID: 34507356 Free PMC article. No abstract available.

4

Targeting The Tumor Microenvironment in Lymphomas: Emerging Biological Insights and Therapeutic Strategies.

Cook MR, Dunleavy K. Cook MR, et al. Among authors: dunleavy k. Curr Oncol Rep. 2022 Sep;24(9):1121-1131. doi: 10.1007/s11912-022-01250-y. Epub 2022 Apr 11. Curr Oncol Rep. 2022. PMID: 35403972 Review.

5

[No title available]

[No authors listed] [No authors listed] PMID: 35453143

6

CAR T-cell therapy in highly aggressive B-cell lymphoma: emerging biological and clinical insights.

Ali A, Goy A, Dunleavy K. Ali A, et al. Among authors: dunleavy k. Blood. 2022 Sep 29;140(13):1461-1469. doi: 10.1182/blood.2022016226. Blood. 2022. PMID: 35560330 Free article.

7

Prognostic factors for adult patients with Burkitt lymphoma treated with dose-adjusted EPOCH-R.

Lakhotia R, Dunleavy K, Abramson JS, Link BK, Powell BL, Melani C, Lucas AN, Steinberg SM, Friedberg JW, Kahl BS, Little RF, Bartlett NL, Noy A, Wilson WH, Roschewski M. Lakhotia R, et al. Among authors: dunleavy k. Blood Adv. 2023 Sep 26;7(18):5320-5324. doi: 10.1182/bloodadvances.2023010223. Blood Adv. 2023. PMID: 37389844 Free PMC article.

8

Differential efficacy of bortezomib plus chemotherapy within molecular subtypes of diffuse large B-cell lymphoma.

Dunleavy K, Pittaluga S, Czuczman MS, Dave SS, Wright G, Grant N, Shovlin M, Jaffe ES, Janik JE, Staudt LM, Wilson WH. Dunleavy K, et al. Blood. 2009 Jun 11;113(24):6069-76. doi: 10.1182/blood-2009-01-199679. Epub 2009 Apr 20. Blood. 2009. PMID: 19380866 Free PMC article.

9

Sobering realities of surviving Hodgkin lymphoma.

Dunleavy K, Bollard CM. Dunleavy K, et al. Blood. 2011 Feb 10;117(6):1772-3. doi: 10.1182/blood-2010-11-317131. Blood. 2011. PMID: 21310929 Free article. No abstract available.

10

Treatment factors affecting outcomes in HIV-associated non-Hodgkin lymphomas: a pooled analysis of 1546 patients.

Barta SK, Xue X, Wang D, Tamari R, Lee JY, Mounier N, Kaplan LD, Ribera JM, Spina M, Tirelli U, Weiss R, Galicier L, Boue F, Wilson WH, Wyen C, Oriol A, Navarro JT, Dunleavy K, Little RF, Ratner L, Garcia O, Morgades M, Remick SC, Noy A, Sparano JA. Barta SK, et al. Among authors: dunleavy k. Blood. 2013 Nov 7;122(19):3251-62. doi: 10.1182/blood-2013-04-498964. Epub 2013 Sep 6. Blood. 2013. PMID: 24014242 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

192 results

Search Page